GHRP-6 vs Ipamorelin
GHRP-6 and Ipamorelin are both growth-hormone-releasing peptides acting on the ghrelin receptor, but they differ in selectivity, which is the usual focus when they are compared in research.
GHRP-6
Growth hormone releasing peptide-6 — classic GH research compound.
Ipamorelin
Synthetic pentapeptide ghrelin receptor agonist supplied for in-vitro receptor-binding and signalling research.
| GHRP-6 | Ipamorelin | |
|---|---|---|
| Class | Growth-hormone-releasing peptide (GHRP) | Growth-hormone-releasing peptide (GHRP) |
| Generation | Earlier-generation GHRP | Later-generation, selectivity-focused |
| Research note | Studied for pronounced appetite-pathway signalling | Studied for a cleaner GH-selective profile |
| Receptor | GH-secretagogue receptor | GH-secretagogue receptor |
Common questions
Is Ipamorelin more selective than GHRP-6 in research?
Research literature generally frames Ipamorelin as the more selective of the two, with GHRP-6 studied for stronger appetite-related pathway signalling. Both act on the GH-secretagogue receptor.
For research use only. Products are supplied for in-vitro laboratory research and are not for human or veterinary use. Comparison describes research context and mechanism only; it is not guidance for use.